In fact, the anti-tumor effect was so effective that two mice treated with expanded PB β
NKs and one mouse treated with expanded iPSC β
NKs had bioluminescent values similar to the negative
control mice suggesting that long - term expanded NK
cells may represent an exciting new treatment modality.
CD4ΞΆ - hESC -
NKs cells were observed in peripheral blood early at day 6 at which point CD4 T -
cell counts rose compared in NK treated mice compared to
control, which gained significance by day 12, demonstrating suppression of HIV activity.